IV plerixafor combined with G-CSF is highly effective for stem cell mobilization in lymphoma patients undergoing autologous stem cell collection

被引:0
|
作者
Cashen, A. [1 ]
Rettig, M. [1 ]
Gao, F. [1 ]
Reineck, T. [1 ]
Abboud, C. [1 ]
Stockerl-Goldstein, K. [1 ]
Vij, R. [1 ]
Uy, G. [1 ]
Westervelt, P. [1 ]
DiPersio, J. [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S33 / S33
页数:1
相关论文
共 50 条
  • [31] Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program
    P Shaughnessy
    J Uberti
    S Devine
    R T Maziarz
    J Vose
    I Micallef
    E Jacobsen
    J McCarty
    P Stiff
    A Artz
    E D Ball
    R Berryman
    M Dugan
    R Joyce
    F J Hsu
    D Johns
    P McSweeney
    Bone Marrow Transplantation, 2013, 48 : 777 - 781
  • [32] Investigation of stem cell mobilization using G-CSF and plerixafor in experimental autoimmune encephalomyelitis
    Oberhagemann, S. M.
    Ladigan, S.
    Marte, H.
    Heitmann, N.
    Nilius, V.
    Gold, R.
    Schroers, R.
    Faissner, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 221 - 222
  • [33] Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF
    G W Basak
    W Wiktor-Jedrzejczak
    J F Apperley
    K W Douglas
    I H Gabriel
    C Geraldes
    K Hübel
    O Jaksic
    Z Koristek
    F Lanza
    R Lemoli
    G Mikala
    D Selleslag
    N Worel
    M Mohty
    R F Duarte
    Bone Marrow Transplantation, 2012, 47 : 1003 - 1005
  • [34] A retrospective study of autologous stem cell mobilization by G-CSF in combination with chemotherapy in patients with multiple myeloma and lymphoma
    Zheng, Gaofeng
    He, Jingsong
    Cai, Zhen
    He, Donghua
    Luo, Yi
    Shi, Jimin
    Wei, Guoqing
    Sun, Jie
    Zheng, Weiyan
    ONCOLOGY LETTERS, 2020, 19 (01) : 1051 - 1059
  • [35] Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program
    Shaughnessy, P.
    Uberti, J.
    Devine, S.
    Maziarz, R. T.
    Vose, J.
    Micallef, I.
    Jacobsen, E.
    McCarty, J.
    Stiff, P.
    Artz, A.
    Ball, E. D.
    Berryman, R.
    Dugan, M.
    Joyce, R.
    Hsu, F. J.
    Johns, D.
    McSweeney, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 (06) : 777 - 781
  • [36] Plerixafor in myeloma and lymphoma patients undergoing autologous stem cell transplantation
    Zielinska, P.
    Markiewicz, M.
    Helbig, G.
    Mietla, M. Dzierzak
    Yrcz-Krzemien, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S347 - S347
  • [37] Mobilization and collection of cells in the hematologic compartment for cellular therapies: Stem cell collection with G-CSF/plerixafor, collecting lymphocytes/monocytes
    Allen, Elizabeth S.
    Conry-Cantilena, Cathy
    SEMINARS IN HEMATOLOGY, 2019, 56 (04) : 248 - 256
  • [38] PLERIXAFOR FOR AUTOLOGOUS STEM-CELL MOBILIZATION AND COLLECTION IN A PORTUGUESE CENTRE
    Pombal, Rita
    Lopes, Sara
    Salselas, Ana
    Roncon, Susana
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 615 - 616
  • [39] Efficacy of Plerixafor Administered At 5:00PM for Stem Cell Mobilization in Lymphoma and Myeloma Patients Undergoing Autologous Stem Cell Transplant
    Tornatta, Jennifer
    Maciejewski, John J.
    Nathan, Sunita
    Mcleod, Bruce
    Palaparthy, Sridevi
    Rich, Elizabeth Shima
    Christopherson, Kent W., II
    Gregory, Stephanie A.
    Fung, Henry C.
    BLOOD, 2011, 118 (21) : 1734 - 1735
  • [40] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
    A D Sung
    D T Grima
    L M Bernard
    S Brown
    G Carrum
    L Holmberg
    M E Horwitz
    J L Liesveld
    J Kanda
    B McClune
    P Shaughnessy
    G J Tricot
    N J Chao
    Bone Marrow Transplantation, 2013, 48 : 1444 - 1449